The Discovery & Development Europe 2026 focuses on guiding biopharma from target identification to clinical candidate, with strategies to optimize early R&D and accelerate drug development.
Key Topics
Scientific and technical case studies on best practices across the R&D pipeline
Spotlights on novel targets, including innovative biologics and small molecules beyond RO5
Formulation and delivery bottleneck identification and resolution
Deep dives into unmet disease areas, with a focus on neuroscience
Automation and AI for improving lab productivity in R&D
Strategies for accelerating target identification to clinical candidate development
Balancing safety, efficacy, and innovation in drug development
Who should Attend
R&D scientists and biopharma researchers
Drug development professionals
Biopharma leaders and executives
Formulation and delivery experts
Biomedical engineers focused on lab productivity
Professionals interested in automation and AI in R&D
Venue
Estrel Congress Center (ECC), Ziegrastraße 225, Berlin, Germany
